Insmed Inc
About
Insmed Inc (NASDAQ:INSM) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
Insmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026
Apr 7 2026
Insmed Provides Clinical Update on Phase 2b CEDAR Study
Mar 23 2026
Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease
Feb 19 2026
Insmed Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Business Update
Feb 13 2026
Insmed To Present at March 2026 Investor Conferences
Financials
Revenue
$606.42 M
Market Cap
$35.01 B
EPS
-6.42